Content

Welcome to the CJU website » LOG IN

Details

Options and recent advances in permanent brachytherapy for prostate cancer
Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
Dec 2007 (Vol. 14, Issue 61, Pages( 28 - 31)
PMID: 18163942

Abstract

Text-Size + 

  • Permanent interstitial brachytherapy with I-125 or Pd-103 seeds is a well-established approach as single modality for low-risk prostate cancer patients and as part of a multi-modality program for intermediate- and high-risk patients. There are multiple approaches that have been developed to deliver high-quality implants, including pre-planned and real-time intra-operative techniques. In the hands of experienced users, either approach can provide consistently excellent outcomes. We believe that the combination of real-time intra-operative dosimetry and connected seeds may provide for improved consistency due to decreased seed migration.

Current Issue

February 2019, Vol.26 No.1
canadian journal of urology mobile

canadian journal of urology